AMGEN, S.A. secures contract for Antihypertensives Supply of medicines for human use containing the active ingredients Romiplostim Carfilzomib and Etelcalcetide destined for centers within the Valencian Public Health field

Spain, April 27 -- Spain based AMGEN, S.A. has secured contract from Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad for Antihypertensives Supply of medicines for human use containing the active ingredients Romiplostim Carfilzomib and Etelcalcetide destined for centers within the Valencian Public Health field. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....